Market Overview:
The global real-time PCR detection systems market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for molecular diagnostics and rising prevalence of infectious diseases. In addition, technological advancements in real-time PCR detection systems are also contributing to the growth of this market. Based on type, the global real-time PCR detection systems market is segmented into instruments and reagents. The instruments segment is further subsegmented into thermal cyclers, mixers/pumps, and detectors/analyzers. The reagents segment is further subsegmented into probes, primers, enzymes, buffers & dNTPs, and others (labels & kits). Based on application, the global real-time PCR detection systems market is divided into clinical nucleic acid detection (including viral load testing), molecular diagnosis (including genetic testing), life science research (including gene expression profiling), food safety & quality control testing., and other applications (such as environmental monitoring).
Product Definition:
Real-time PCR detection systems are used to detect minute levels of specific DNA sequences in a sample. This allows for more accurate and sensitive detection than traditional methods, which can be prone to false positives. The importance of real-time PCR detection systems is that they allow for the identification of very small amounts of genetic material, which can be used to diagnose diseases or determine the presence or absence of a particular gene.
Instrument:
Instruments are used for performing specific tasks in molecular biology. They have become an essential part of life sciences and research workflows. The development of novel technologies has led to the introduction of a number of new instruments, which have further accelerated the market growth.
Reagent:
Reagents are chemicals that help in performing a specific task during the PCR detection. It is one of the most important parts of any PCR-based testing procedure as it helps amplify the DNA specimen and detect its presence in a specific time frame. The reagent market is highly competitive and fragmented with many small companies offering products similar to those offered by established players such as Roche, Thermo Fisher Scientific, PerkinElmer etc.
Application Insights:
The clinical nucleic acid detection segment dominated the global real-time PCR detection systems market in 2017. This is attributed to the rising prevalence of chronic diseases, such as cancer and genetic disorders, which mandates rapid molecular diagnostic procedures for identifying the cause of a disease. Moreover, an increase in spending on diagnostics by healthcare companies is expected to fuel segment growth during the forecast period.
Molecular diagnosis segment is anticipated to grow at a lucrative rate over the forecast period due to increasing demand for highly accurate and sensitive molecular diagnostic tests that provide information regarding disease etiology and patient prognosis. Furthermore, an increase in R&D investments by major players for developing advanced real-time PCR techniques will further boost product demand over the next seven years.
Regional Analysis:
North America dominated the global real-time PCR detection systems market in 2017. This is due to the presence of a large number of players, high investment in research and development, and increased focus on clinical diagnostics by regulatory bodies. The U.S.-based companies are involved in strategic initiatives such as partnerships for product launches with other companies or acquisitions to expand their reach across other regions. For instance, earlier this year (May 2018), Bio-Rad launched Reagent kits for NGS Genomics SMiSeq platform that enable rapid NGS based genetic analysis using the Illumina’s MiSeq platform; these kits include reagents required for sequencing reactions such as First Strand DNA kit & Power SYBR Green PCR Kit from Qiagen).
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests
- Rising prevalence of infectious diseases
- Technological advancements in real-time PCR detection systems
- Growing demand for personalized medicine
- Increasing funding for research and development in life sciences sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Real-Time PCR Detection Systems Market Research Report
By Type
Instrument, Reagent
By Application
Clinical Nucleic Acid Detection, Molecular Diagnosis, Life Science Research
By Companies
Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Techne, Bio-Rad
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Real-Time PCR Detection Systems Market Report Segments:
The global Real-Time PCR Detection Systems market is segmented on the basis of:
Types
Instrument, Reagent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Nucleic Acid Detection, Molecular Diagnosis, Life Science Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Roche
- QIAGEN
- Bio-rad
- Agilent
- Bioer
- Biosynex
- Esco
- Analytik Jena
- Techne
- Bio-Rad
Highlights of The Real-Time PCR Detection Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instrument
- Reagent
- By Application:
- Clinical Nucleic Acid Detection
- Molecular Diagnosis
- Life Science Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Real-Time PCR Detection Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Real-time PCR detection systems are used to identify specific DNA sequences in a sample. These systems use fluorescent dyes and enzymes to create a real-time image of the DNA sequence as it is being amplified. This allows for quick and accurate identification of specific genetic markers.
Some of the major players in the real-time pcr detection systems market are Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, Bioer, Biosynex, Esco, Analytik Jena, Techne, Bio-Rad.
The real-time pcr detection systems market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Real-Time PCR Detection Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Real-Time PCR Detection Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Real-Time PCR Detection Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Real-Time PCR Detection Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Real-Time PCR Detection Systems Market Size & Forecast, 2018-2028
4.5.1 Real-Time PCR Detection Systems Market Size and Y-o-Y Growth
4.5.2 Real-Time PCR Detection Systems Market Absolute $ Opportunity
Chapter 5 Global Real-Time PCR Detection Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Real-Time PCR Detection Systems Market Size Forecast by Type
5.2.1 Instrument
5.2.2 Reagent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Real-Time PCR Detection Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Real-Time PCR Detection Systems Market Size Forecast by Applications
6.2.1 Clinical Nucleic Acid Detection
6.2.2 Molecular Diagnosis
6.2.3 Life Science Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Real-Time PCR Detection Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Real-Time PCR Detection Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Real-Time PCR Detection Systems Analysis and Forecast
9.1 Introduction
9.2 North America Real-Time PCR Detection Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Real-Time PCR Detection Systems Market Size Forecast by Type
9.6.1 Instrument
9.6.2 Reagent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Real-Time PCR Detection Systems Market Size Forecast by Applications
9.10.1 Clinical Nucleic Acid Detection
9.10.2 Molecular Diagnosis
9.10.3 Life Science Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Real-Time PCR Detection Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Real-Time PCR Detection Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Real-Time PCR Detection Systems Market Size Forecast by Type
10.6.1 Instrument
10.6.2 Reagent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Real-Time PCR Detection Systems Market Size Forecast by Applications
10.10.1 Clinical Nucleic Acid Detection
10.10.2 Molecular Diagnosis
10.10.3 Life Science Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Real-Time PCR Detection Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Real-Time PCR Detection Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Real-Time PCR Detection Systems Market Size Forecast by Type
11.6.1 Instrument
11.6.2 Reagent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Real-Time PCR Detection Systems Market Size Forecast by Applications
11.10.1 Clinical Nucleic Acid Detection
11.10.2 Molecular Diagnosis
11.10.3 Life Science Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Real-Time PCR Detection Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Real-Time PCR Detection Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Real-Time PCR Detection Systems Market Size Forecast by Type
12.6.1 Instrument
12.6.2 Reagent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Real-Time PCR Detection Systems Market Size Forecast by Applications
12.10.1 Clinical Nucleic Acid Detection
12.10.2 Molecular Diagnosis
12.10.3 Life Science Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Real-Time PCR Detection Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Real-Time PCR Detection Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Real-Time PCR Detection Systems Market Size Forecast by Type
13.6.1 Instrument
13.6.2 Reagent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Real-Time PCR Detection Systems Market Size Forecast by Applications
13.10.1 Clinical Nucleic Acid Detection
13.10.2 Molecular Diagnosis
13.10.3 Life Science Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Real-Time PCR Detection Systems Market: Competitive Dashboard
14.2 Global Real-Time PCR Detection Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher
14.3.2 Roche
14.3.3 QIAGEN
14.3.4 Bio-rad
14.3.5 Agilent
14.3.6 Bioer
14.3.7 Biosynex
14.3.8 Esco
14.3.9 Analytik Jena
14.3.10 Techne
14.3.11 Bio-Rad
